RISK-FACTORS FOR INFECTION OF ADULT PATIENTS WITH CANCER WHO HAVE TUNNELED CENTRAL VENOUS CATHETERS

被引:0
作者
HOWELL, PB
WALTERS, PE
DONOWITZ, GR
FARR, BM
机构
[1] UNIV VIRGINIA,HLTH SCI CTR,DEPT MED,CHARLOTTESVILLE,VA 22908
[2] UNIV VIRGINIA,DEPT NURSING,CHARLOTTESVILLE,VA 22908
关键词
COHORT STUDY; EPIDEMIOLOGY; CANCER; CENTRAL VENOUS CATHETER; NEUTROPENIA; SEPSIS;
D O I
10.1002/1097-0142(19950315)75:6<1367::AID-CNCR2820750620>3.0.CO;2-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Long-dwelling tunnelled central venous catheters provide reliable access for infusion therapy of patients with cancer, but can result in serious bloodstream infections. The incidence of such infections has been documented, but few studies have assessed potential risk factors, and to the authors' knowledge, none have measured the effect of neutropenia upon the incidence of these infections. Methods. A cohort of 71 adult patients with cancer with long-dwelling tunnelled central venous catheters was followed for a total of 12,410 catheter days until catheter removal, death, or end of study for the occurrence of catheter-related infection or sepsis of unknown origin. Fifteen factors were assessed for association with these infections. Results. Thirteen patients (18%) experienced a catheter-related infection (1.0/1000 catheter days), and 23 (32%) experienced sepsis of unknown origin. Neutropenia was associated significantly with risk for catheter-related infection (relative risk [RR] = 15.1, 95% confidence interval [CI] 2.7-86.9) and sepsis of unknown origin (RR = 10.3, 95% CI 4.0-26.8). Inpatient status, acute leukemia, and cytosine arabinoside therapy also were associated with sepsis of unknown origin, but not when adjusted for neutropenia. Conclusion. Of the 15 potential risk factors studied, neutropenia was the only independent risk factor for infection related to long-dwelling tunnelled central venous catheters and for sepsis of unknown origin.
引用
收藏
页码:1367 / 1375
页数:9
相关论文
共 62 条
[1]   A PROSPECTIVE-STUDY OF PROLONGED CENTRAL VENOUS ACCESS IN LEUKEMIA [J].
ABRAHM, JL ;
MULLEN, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (21) :2868-2873
[2]  
ALSIBAI MB, 1987, CANCER, V60, P1891, DOI 10.1002/1097-0142(19871015)60:8<1891::AID-CNCR2820600836>3.0.CO
[3]  
2-Z
[4]   CONTAMINANT BLOOD CULTURES AND RESOURCE UTILIZATION - THE TRUE CONSEQUENCES OF FALSE-POSITIVE RESULTS [J].
BATES, DW ;
GOLDMAN, L ;
LEE, TH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (03) :365-369
[5]   RISK OF INFECTION ASSOCIATED WITH THE USE OF BROVIAC AND HICKMAN CATHETERS [J].
BEGALA, JE ;
MAHER, K ;
CHERRY, JD .
AMERICAN JOURNAL OF INFECTION CONTROL, 1982, 10 (01) :17-23
[6]  
BENEZRA D, 1988, AM J MED, V85, P495
[7]  
BLACKLOCK HA, 1980, LANCET, V1, P993
[8]   THE VALUE OF THE HICKMAN-TYPE RIGHT ATRIAL CATHETER FOR VENOUS ACCESS IN CANCER-PATIENTS [J].
BRAITHWAITE, PA ;
RUST, VJ ;
LOWENTHAL, RM .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1981, 51 (04) :359-363
[9]   RELIABILITY OF BLOOD CULTURES COLLECTED FROM INTRAVASCULAR CATHETER VERSUS VENIPUNCTURE [J].
BRYANT, JK ;
STRAND, CL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 88 (01) :113-116
[10]   CLASSICAL EXTERNAL INDWELLING CENTRAL VENOUS CATHETER VERSUS TOTALLY IMPLANTED VENOUS ACCESS SYSTEMS FOR CHEMOTHERAPY ADMINISTRATION - A RANDOMIZED TRIAL IN 100 PATIENTS WITH SOLID TUMORS [J].
CARDE, P ;
COSSETDELAIGUE, MF ;
LAPLANCHE, A ;
CHAREAU, I .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (06) :939-944